I do believe the burns trials phase 1/2 are being funded by the WA government in conjunction with Fiona Stanley hospital at no cost to Recce other than supply of the compound.
Recce seems to be very shrewd in looking for opportunities to get others to carry the cost of research, out of the many places currently test our compounds I believe (could be wrong) the intravenous phase 1 trial at CMAX is the only one we are paying for other than in house preclinical.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-10
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
61.5¢ |
Change
-0.005(0.81%) |
Mkt cap ! $122.3M | |||
| Open | High | Low | Value | Volume |
| 62.0¢ | 63.5¢ | 60.0¢ | $59.80K | 98.70K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1666 | 61.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 62.5¢ | 1736 | 1 |
View Market Depth
| Last trade - 14.41pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
62.0¢ |
Change
-0.005 ( 2.36 %) |
||||
| Open | High | Low | Volume | ||
| 61.5¢ | 63.0¢ | 60.0¢ | 37667 | ||
| Last updated 14.29pm 15/05/2024 ? | |||||
| RCE (ASX) Chart |